|
1
|
Frieden IJ, Haggstrom AN, Drolet BA, et
al: Infantile hemangiomas: Current knowledge, future directions.
In: Proceedings of a research workshop on infantile hemangiomas;
April 7–9, 2005; Bethesda. Maryland, USA
Pediatr Dermatol. 22:pp. 383–406. 2005
|
|
2
|
Zimmermann AP, Wiegand S, Werner JA and
Eivazi B: Propranolol therapy for infantile haemangiomas: Review of
the literature. Int J Pediatr Otorhinolaryngol. 74:338–342. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Eivazi B, Ardelean M, Bäumler W, et al:
Update on hemangiomas and vascular malformations of the head and
neck. Eur Arch Otorhinolaryngol. 266:187–197. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Werner JA, Dünne AA, Lippert BM and Folz
BJ: Optimal treatment of vascular birthmarks. Am J Clin Dermatol.
4:745–756. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Amer TA, Elwakil TF and Elbasiouny MS:
Open rhinoplasty for treatment of nasal tip haemangioma. Eur J
Plast Surg. 30:67–73. 2007. View Article : Google Scholar
|
|
6
|
Kono T, Sakurai H, Groff WF, et al:
Comparison study of a traditional pulsed dye laser versus a
long-pulsed dye laser in the treatment of early childhood
hemangiomas. Lasers Surg Med. 38:112–115. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Marler JJ and Mulliken JB: Current
management of hemangiomas and vascular malformations. Clin Plast
Surg. 32:99–116. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sans V, de la Roque ED, Berge J, et al:
Propranolol for severe infantile hemangiomas: Follow-up report.
Pediatrics. 124:e423–e431. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Léauté-Labrèze C, Dumas de la Roque E,
Hubiche T, Boralevi F, Thambo JB and Taïeb A: Propranolol for
severe hemangiomas of infancy. N Engl J Med. 358:2649–2651. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Love JN and Sikka N: Are 1–2 tablets
dangerous? Beta-blocker exposure in toddlers. J Emerg Med.
26:309–314. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Denoyelle F, Leboulanger N, Enjolras O,
Harris R, Roger G and Garabedian EN: Role of Propranolol in the
therapeutic strategy of infantile laryngotracheal hemangioma. Int J
Pediatr Otorhinolaryngol. 73:1168–1172. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Holmes WJ, Mishra A, Gorst C and Liew SH:
Propranolol as first-line treatment for infantile hemangiomas.
Plast Reconstr Surg. 125:420–421. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jephson CG, Manunza F, Syed S, Mills NA,
Harper J and Hartley BE: Successful treatment of isolated
subglottic haemangioma with propranolol alone. Int J Pediatr
Otorhinolaryngol. 73:1821–1823. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Michel JL and Patural H: Response to oral
propranolol therapy for ulcerated hemangiomas in infancy. Arch
Pediatr. 16:1565–1568. 2009.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Blei F: Basic science and clinical aspects
of vascular anomalies. Curr Opin Pediatr. 17:501–509. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chang MW: Updated classification of
hemangiomas and other vascular anomalies. Lymphat Res Biol.
1:259–265. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Storch CH and Hoeger PH: Propranolol for
infantile haemangiomas: insights into the molecular mechanisms of
action. Br J Dermatol. 163:269–274. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peridis S, Pilgrim G, Athanasopoulos I and
Parpounas K: A meta-analysis on the effectiveness of propranolol
for the treatment of infantile airway haemangiomas. Int J Pediatr
Otorhinolaryngol. 75:455–460. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schiestl C, Neuhaus K, Zoller S, et al:
Efficacy and safety of propranolol as first-line treatment for
infantile hemangiomas. Eur J Pediatr. 170:493–501. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Holmes WJ, Mishra A, Gorst C and Liew SH:
Propranolol as first-line treatment for rapidly proliferating
infantile haemangiomas. J Plast Reconstr Aesthet Surg. 64:445–451.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Denoyelle F and Garabédian EN: Propranolol
may become first-line treatment in obstructive subglottic infantile
hemangiomas. Otolaryngol Head Neck Surg. 142:463–464. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
de Graaf M, Breur JM, Raphaël MF, Vos M,
Breugem CC and Pasmans SG: Adverse effects of propranolol when used
in the treatment of hemangiomas: A case series of 28 infants. J Am
Acad Dermatol. 65:320–327. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xiao Q, Li Q, Zhang B and Yu W:
Propranolol therapy of infantile hemangiomas: efficacy, adverse
effects, and recurrence. Pediatr Surg Int. 29:575–581. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Szychta P, Stewart K and Anderson W:
Treatment of infantile hemangiomas with propranolol: clinical
guidelines. Plast Reconstr Surg. 133:852–862. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chang LC, Haggstrom AN, Drolet BA, et al:
Growth characteristics of infantile hemangiomas: Implications for
management. Pediatrics. 122:360–367. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim HJ, Colombo M and Frieden IJ:
Ulcerated hemangiomas: Clinical characteristics and response to
therapy. J Am Acad Dermatol. 44:962–972. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Buckmiller LM, Munson PD, Dyamenahalli U,
Dai Y and Richter GT: Propranolol for infantile hemangiomas: Early
experience at a tertiary vascular anomalies center. Laryngoscope.
120:676–681. 2010. View Article : Google Scholar : PubMed/NCBI
|
